Loading…
Neuronetics, Inc. is projected to rise to $2.99 by 2027, a +51% move from its current price of $1.98. STIM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $1.87 | $1.98 | $2.09 | +0.01% |
| Aug 5 | $1.83 | $1.98 | $2.14 | +0.01% |
| Aug 6 | $1.80 | $1.98 | $2.18 | +0.02% |
| Aug 7 | $1.77 | $1.98 | $2.21 | +0.03% |
| Aug 8 | $1.75 | $1.98 | $2.24 | +0.03% |
| Aug 9 | $1.73 | $1.98 | $2.27 | +0.04% |
| Aug 10 | $1.71 | $1.98 | $2.30 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.71 | $1.98 | $2.30 | +0.05% |
| Week 2 | $1.61 | $1.98 | $2.44 | +0.10% |
| Week 3 | $1.53 | $1.98 | $2.56 | +0.15% |
| Week 4 | $1.48 | $1.98 | $2.67 | +0.19% |
| Week 5 | $1.43 | $1.98 | $2.76 | +0.24% |
| Week 6 | $1.38 | $1.99 | $2.85 | +0.29% |
| Week 7 | $1.34 | $1.99 | $2.94 | +0.34% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Neuronetics, Inc. is a healthcare company that provides in office treatments for neurohealth disorders in the United States and internationally. It markets the NeuroStar Advanced Therapy System, a non-invasive, office-based treatment for adult patients with major depressive disorder.
The NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists.
Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. It maintains a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology.
Neuronetics, Inc. trades under the STIM symbol and operates in the healthcare sector. The stock’s current price is $1.87 with a market capitalization of $130.13M, and it ranks 3887 by size.
Technically, the trend appears bullish with RSI at 60, supported by a 50-day simple moving average of $1.45 and a 200-day simple moving average of $1.69. Near-term support sits at $1.20 and resistance at $2.02, with a 30-day price range of $1.26 to $2.78.
The long-range forecast shows upside potential across years, with the average price rising from $1.87 in 2026 to higher levels in later years (for example, 2027 avg $3.06, 2030 avg $6.33, and 2050 avg $44.49), and ROIs reaching as high as 2278.9% by 2050. The outlook remains bullish for the multi-year horizon.
A major floor 53.9% below — a decisive break under it would weaken the trend.
The nearest floor, 39.4% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 29.0% above — clearing it would confirm fresh momentum.
Key STIM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of STIM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.89 | Buy | $1.91 | Buy |
| MA 10 | $1.89 | Buy | $1.86 | Buy |
| MA 20 | $1.79 | Buy | $1.77 | Buy |
| MA 50 | $1.50 | Buy | $1.62 | Buy |
| MA 100 | $1.50 | Buy | $1.60 | Buy |
| MA 200 | $1.67 | Buy | $1.82 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.97 | Neutral |
| Stoch RSI (14) | 43.19 | Neutral |
| CCI (20) | 114.08 | Buy |
| Williams %R (14) | -10.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 7.61 | Buy |
| Bollinger %B (20,2) | 0.84 | Neutral |
| Stochastic %K (14) | 90.00 | Sell |
| TRIX (15) | 1.18 | Buy |
| Awesome (5,34) | 0.31 | Buy |
| Ultimate (7,14,28) | 57.00 | Neutral |
| Momentum (10) | 0.36 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 1.93 | Buy |
| ADX (14) | 21.30 | Buy |
| ATR (14) | 0.08 | Info |
Near-term technical picture is bullish. RSI14 is 60, indicating positive momentum near the neutral line.
The stock trades above the 50-day moving average of $1.45 and the 200-day moving average of $1.69, suggesting a constructive trend. A defined near-term support is at $1.20 and resistance at $2.02, framing the current trading range.
The 30-day price range spans from $1.26 to $2.78, highlighting a broad swing in the near term. Annualized volatility is 100%, underscoring elevated price movement potential within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.18 | $1.98 | $2.58 | 0% | Neutral | |
| $2.18 | $2.99 | $4.43 | +51% | Bullish | |
| $2.80 | $4.09 | $6.47 | +106% | Bullish | |
| $3.12 | $4.80 | $7.98 | +142% | Bullish | |
| $3.70 | $5.97 | $10.34 | +201% | Bullish | |
| $3.38 | $5.70 | $10.22 | +188% | Bullish | |
| $3.18 | $5.59 | $10.34 | +182% | Bullish | |
| $3.80 | $6.95 | $13.22 | +251% | Bullish | |
| $5.05 | $9.62 | $18.75 | +386% | Bullish | |
| $6.18 | $12.24 | $24.41 | +518% | Bullish | |
| $7.35 | $16.32 | $35.80 | +724% | Bullish | |
| $16.37 | $36.37 | $83.65 | +17.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.18 | $1.98 | $2.28 | +0.00% |
| September 2026 | $1.49 | $1.82 | $2.31 | -8.24% |
| October 2026 | $1.62 | $1.99 | $2.58 | +9.67% |
| November 2026 | $1.63 | $2.03 | $2.67 | +1.85% |
| December 2026 | $1.53 | $1.93 | $2.58 | -4.82% |
Click any year to see its month-by-month STIM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, STIM could reach as high as $2.58, with a base case around $1.98 and support toward $1.18 — roughly 0% from $1.98. Price action looks broadly range-bound.
Expect STIM to range from $2.18 to $4.43 through 2027. The $2.99 average target implies a +51% move from current prices. That is up +51% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The STIM price prediction for 2028 points to an average of $4.09 (low $2.80, high $6.47) — a potential gain of +106% on today's $1.98. Momentum favours further upside here.
In 2029, STIM is projected to trade between $3.12 and $7.98, averaging $4.80 — a potential gain of +142% from today's $1.98. That is up +17% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Neuronetics, Inc.'s 2030 outlook centres on $5.97, within a $3.70 to $10.34 range. That is up +24% on the projected 2029 average. That marks a +201% change versus current levels. Momentum favours further upside here.
By 2031, STIM could reach as high as $10.22, with a base case around $5.70 and support toward $3.38 — roughly +188% from $1.98. Buyers look set to stay in control over this stretch.
Expect STIM to range from $3.18 to $10.34 through 2032. The $5.59 average target implies a +182% move from current prices. That is -2% versus the projected 2031 average. Momentum favours further upside here.
The STIM price prediction for 2033 points to an average of $6.95 (low $3.80, high $13.22) — a potential gain of +251% on today's $1.98. Buyers look set to stay in control over this stretch.
In 2034, STIM is projected to trade between $5.05 and $18.75, averaging $9.62 — a potential gain of +386% from today's $1.98. That is up +38% on the projected 2033 average. Momentum favours further upside here.
Neuronetics, Inc.'s 2035 outlook centres on $12.24, within a $6.18 to $24.41 range. That is up +27% on the projected 2034 average. That marks a +518% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, STIM could reach as high as $35.80, with a base case around $16.32 and support toward $7.35 — roughly +724% from $1.98. Momentum favours further upside here.
Expect STIM to range from $16.37 to $83.65 through 2050. The $36.37 average target implies a +17.4x move from current prices. That is up +123% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in STIM today (≈ 505.050505 STIM) could be worth
$18,368.74
+$17,368.74 (+1737%) by 2050 · US Dollar
Based on the average projected STIM price of $36.37 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in STIMwould be worth at today's price.
$1,000 invested in STIM on Jul 31, 2025 (≈ 227.79044 STIM) would be worth
$451.03
-$548.97 (-54.9%) today · 0.45× · US Dollar
Based on a STIM entry price of $4.39 vs. today's $1.98.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.73 | $1,144.51 | +14.5% |
| 1 month ago | $1.35 | $1,466.67 | +46.7% |
| 3 months ago | $2.02 | $980.2 | -2.0% |
| 6 months ago | $1.99 | $994.97 | -0.5% |
| 1 year ago | $4.39 | $451.03 | -54.9% |
| All time (5.0y) ago | $7.85 | $252.23 | -74.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our STIM forecast.
Our base-case forecast reaches $4.00 around 2028.
Implied market cap at $4.00: $278.35M
Over the multi-year horizon, the forecast shows sustained bullish sentiment with rising averages: 2027 avg $3.06, 2028 avg $4.19, 2029 avg $4.95, 2030 avg $6.33, 2031 avg $5.99, 2032 avg $6.01, 2033 avg $7.99, 2034 avg $11.04, 2035 avg $13.91, 2040 avg $19.74, and 2050 avg $44.49.
Projected ROI strengthens over time: 2027 63.8%, 2028 124.2%, 2029 164.8%, 2030 238.6%, 2031 220.2%, 2032 221.4%, 2033 327.2%, 2034 490.2%, 2035 644.1%, 2040 955.8%, and 2050 2278.9%.
The outlook remains bullish across the longer horizon, with higher expected averages and sizable ROIs. These figures are estimates and do not guarantee future results; actual performance may vary based on market conditions and other factors.
Tap a question to reveal the answer.
2030 avg $6.33; min $3.92; max $10.97; ROI 238.6%; sentiment bullish.
Forecasts show bullish sentiment from 2027 onward with notable upside: 2027 avg $3.06, 2030 avg $6.33, 2040 avg $19.74, and 2050 avg $44.49, with ROIs up to 2278.9% by 2050. These are estimates and not guarantees.
Yes, the 2027 forecast includes a max of $4.55 and an average of $3.06.
Current price is $1.87 and market cap is $130.13M.
The 30-day range is $1.26 to $2.78.
Neuronetics, Inc. Community Discussion
0Share your Neuronetics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.